E. C. Lawrence
Houston Methodist Hospital
7 Papers
228 Citations
E. C. Lawrence is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 5, co-authored 7 publications.
Chat about Author
Papers
•Journal Article
Evolution of hemodynamics after orthotopic heart and heart-lung transplantation: early restrictive patterns persisting in occult fashion.
James B. Young,C. A. Leon,H. D. Short,George P. Noon,E. C. Lawrence,H. H. Whisennand,Craig M. Pratt,D. A. Goodman,Donald G. Weilbaecher,Miguel A. Quinones +9 more
TL;DR: A characteristic evolvement of hemodynamics in heart and heart-lung transplants that mimic dynamics associated with restrictive myocardial disease is documented.
112
Elevated serum levels of soluble interleukin-2 receptors in active pulmonary sarcoidosis: relative specificity and association with hypercalcemia.
E. C. Lawrence,Berger Mb,Brousseau Kp,Rodriguez Tm,Siegel Sj,Kurman Cc,Nelson Dl +6 more
- 01 Sep 1987
TL;DR: It is concluded that marked serum elevations of soluble IL-2R are more suggestive of active pulmonary sarcoidosis than IPF.
43
Dynamic Changes in Soluble Interleukin-2 Receptor Levels after Lung or Heart-Lung Transplantation
E. C. Lawrence,V. A. Holland,James B. Young,N. T. Windsor,Brousseau Kp,George P. Noon,H. H. Whisennand,Michael E. DeBakey,Nelson Dl +8 more
TL;DR: It is concluded that marked elevations of soluble IL-2R are associated with rejection, intermediate elevations with either rejection or infection, and that low levels of soluble IDR exclude rejection.
39
•Journal Article
Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy.
James B. Young,K. S. Lloyd,N. T. Windsor,B. Cocanougher,Donald G. Weilbaecher,Neal S. Kleiman,F. W. Smart,D. L. Nelson,E. C. Lawrence +8 more
TL;DR: Late morbidity and mortality after heart transplantation seem predicted by early elevation of plasma soluble interleukin-2 receptor levels.
23
Pulmonary function after heart-lung transplantation using larger donor organs.
TL;DR: Within limits, larger donor lungs appear to adapt to the constraints of the recipient chest and may be used with clinical success, without apparent adverse effects.
19